Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | EVP and CRO | March 13, 2017 | March 15, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date March 13, 2017 · Filed March 15, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.15 · Expires 2027-03-13 | Direct | 400,000 |
Reported balance
After 2017-03-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-03-13 · Grant · Acquired 400,000 · Balance 400,000 F2: Granted under Teladoc's 2017 Inducement Award Plan. F1: The option will vest as to 25% of the shares on March 13, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The option will vest as to 25% of the shares on March 13, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter.
F2: Granted under Teladoc's 2017 Inducement Award Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2017 Filed Mar 15, 2017 16:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001179110-17-004617 · edgar.xml · derivative · entry 1 Nieves Peter N. · CIK 0001700954 · EVP and CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2027-03-13 F2 · shares: Granted under Teladoc's 2017 Inducement Award Plan. F1 · derivative.exercise_date: The option will vest as to 25% of the shares on March 13, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.